Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial

BACKGROUND: Although the release of cardiac biomarkers after percutaneous (PCI) or surgical revascularization (CABG) is common, its prognostic significance is not known. Questions remain about the mechanisms and degree of correlation between the release, the volume of myocardial tissue loss, and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hueb, Whady, Gersh, Bernard J, Rezende, Paulo Cury, Garzillo, Cibele Larrosa, Lima, Eduardo Gomes, Vieira, Ricardo D'Oliveira, Garcia, Rosa Maria Rahmi, Favarato, Desiderio, Segre, Carlos Alexandre W, Pereira, Alexandre Costa, Soares, Paulo Rogério, Ribeiro, Expedito, Lemos, Pedro, Perin, Marco A, Strunz, Célia Cassaro, Dallan, Luis AO, Jatene, Fabio B, Stolf, Noedir AG, Hueb, Alexandre Ciappina, Dias, Ricardo, Gaiotto, Fabio A, da Costa, Leandro Menezes Alves, Oikawa, Fernando Teiichi Costa, de Melo, Rodrigo Morel Vieira, Serrano, Carlos Vicente, de Ávila, Luiz Francisco Rodrigues, Villa, Alexandre Volney, Filho, José Rodrigues Parga, Nomura, César, Ramires, José AF, Filho, Roberto Kalil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468382/
https://www.ncbi.nlm.nih.gov/pubmed/22898311
http://dx.doi.org/10.1186/1471-2261-12-65

Ejemplares similares

Ejemplares similares